Dudediligence.

Cytokinetics, Incorporated

CYTKNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$47.4M

30 notices · 672,913 sh

Oct 2025 to Oct 2026

Reported ·

$32.4M

63 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

53 of 63 reported sales carry the 10b5-1 box. Together they are 0.35% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-15: Robert I. Blum, Form 1442026-09-11: ROBERT LANDRY, Form 1442026-09-01: B LYNNE PARSHALL, Form 1442026-07-30: ANDREW CALLOS, Form 1442026-07-07: FADY MALIK, Form 1442026-07-01: ROBERT BLUM, Form 1442026-06-29: Sung Lee, Form 1442026-06-26: Sung Lee, Form 1442026-06-24: Sung Lee, Form 1442026-06-01: EDWARD KAYE, Form 1442026-05-05: WENDELL WIERENGA, Form 1442026-05-05: JOHN HENDERSON, Form 1442026-05-05: SUNG LEE, Form 1442026-04-15: ANDREW CALLOS, Form 1442026-04-07: FADY MALIK, Form 1442026-04-01: ROBERT BLUM, Form 1442026-03-31: ANDREW CALLOS, Form 1442026-03-18: ANDREW CALLOS, Form 1442026-03-16: ANDREW CALLOS, Form 1442026-03-02: B LYNNE PARSHALL, Form 1442026-01-02: ANDREW CALLOS, Form 1442025-12-29: ANDREW CALLOS, Form 1442025-12-22: WENDELL WIERENGA, Form 1442025-12-05: ANDREW CALLOS, Form 1442025-12-02: JOHN T HENDERSON, Form 1442025-12-01: EDWARD KAYE, Form 1442025-11-19: B LYNNE PARSHALL, Form 1442025-11-11: EDWARD KAYE, Form 1442025-10-27: WENDELL WIERENGA, Form 1442025-10-21: FADY MALIK, Form 1442025-10-07: Malik Fady Ibraham, sold2025-10-16: Blum Robert I, sold2025-10-21: Malik Fady Ibraham, sold2025-10-27: WIERENGA WENDELL, sold2025-10-30: Blum Robert I, sold2025-11-04: Malik Fady Ibraham, sold2025-11-11: Kaye Edward M. MD, sold2025-11-18: Malik Fady Ibraham, sold2025-11-19: PARSHALL B LYNNE, sold2025-12-01: Harrington Robert Arthur, sold2025-12-01: Kaye Edward M. MD, sold2025-12-02: Malik Fady Ibraham, sold2025-12-02: HENDERSON JOHN T, sold2025-12-05: Callos Andrew, sold2025-12-08: Callos Andrew, sold2025-12-16: Malik Fady Ibraham, sold2025-12-22: WIERENGA WENDELL, sold2025-12-29: Callos Andrew, sold2026-01-02: Callos Andrew, sold2026-01-05: Callos Andrew, sold2026-02-02: Callos Andrew, sold2026-02-05: Callos Andrew, sold2026-03-02: Callos Andrew, sold2026-03-02: PARSHALL B LYNNE, sold2026-03-05: Callos Andrew, sold2026-03-09: Blum Robert I, sold2026-03-09: Malik Fady Ibraham, sold2026-03-09: Callos Andrew, sold2026-03-16: Callos Andrew, sold2026-03-17: Blum Robert I, sold2026-03-17: Malik Fady Ibraham, sold2026-03-17: Callos Andrew, sold2026-03-17: Lee Sung, sold2026-03-18: Callos Andrew, sold2026-03-31: Callos Andrew, sold2026-04-01: Blum Robert I, sold2026-04-07: Malik Fady Ibraham, sold2026-04-15: Blum Robert I, sold2026-04-15: Callos Andrew, sold2026-04-21: Malik Fady Ibraham, sold2026-04-29: Blum Robert I, sold2026-04-30: Callos Andrew, sold2026-05-01: Callos Andrew, sold2026-05-05: Callos Andrew, sold2026-05-05: HENDERSON JOHN T, sold2026-05-05: Lee Sung, sold2026-05-05: WIERENGA WENDELL, sold2026-05-05: Malik Fady Ibraham, sold2026-05-14: Blum Robert I, sold2026-05-19: Malik Fady Ibraham, sold2026-05-27: Blum Robert I, sold2026-06-01: PARSHALL B LYNNE, sold2026-06-01: Callos Andrew, sold2026-06-01: Kaye Edward M. MD, sold2026-06-09: Malik Fady Ibraham, sold2026-06-15: Blum Robert I, sold2026-06-23: Malik Fady Ibraham, sold
under a ▼ salesize is dollars

Form 144 notices, newest first

2026-09-15Robert I. Blum, President & CEO$7,094,739
97,926 shplan 2025-12-24Form 4s on file end Jun 23144 ↗
2026-09-11ROBERT LANDRY, Director$147,240
2,000 shplan 2026-06-12Form 4s on file end Jun 23144 ↗
2026-09-01B LYNNE PARSHALL, Director$354,550
5,000 shplan 2025-08-20Form 4s on file end Jun 23144 ↗
2026-07-30ANDREW CALLOS, EVP, Chief Commercial Officer$1,881,240
24,000 shplan 2025-09-05Form 4s on file end Jun 23144 ↗
2026-07-07FADY MALIK, EVP Research & Development$2,096,465
24,500 shplan 2025-12-23Form 4s on file end Jun 23144 ↗
2026-07-01ROBERT BLUM, President & CEO$4,472,475
52,500 shplan 2025-12-24Form 4s on file end Jun 23144 ↗
2026-06-29Sung Lee, EVP, Chief Financial Officer$781,052
9,503 shplan 2025-12-23144 ↗
Form 4, 2026-06-29: sold 3,134 at $85.00 Form 4 ↗
2026-06-26Sung Lee, EVP, Chief Financial Officer$540,956
6,695 shplan 2025-12-23Form 4s on file end Jun 23144 ↗
2026-06-24Sung Lee, EVP, Chief Financial Officer$3,098,787
38,730 shplan 2025-12-23144 ↗
Form 4, 2026-06-29: sold 38,730 at $82.30 Form 4 ↗
2026-06-01EDWARD KAYE, Director$225,137
2,933 shplan 2026-03-02144 ↗
Form 4, 2026-06-01: sold 2,933 at $76.09 Form 4 ↗
2026-05-05WENDELL WIERENGA, Director$266,314
4,032 shplan 2025-05-14144 ↗
Form 4, 2026-05-05: sold 4,032 at $75.00 Form 4 ↗
2026-05-05JOHN HENDERSON, Director$1,321,000
20,000 shplan 2025-09-02144 ↗
Form 4, 2026-05-05: sold 20,000 at $75.97 Form 4 ↗
2026-05-05SUNG LEE, EVP, Chief Financial Officer$1,578,991
23,906 shplan 2025-12-23144 ↗
Form 4, 2026-05-05: sold 23,906 at $76.87 Form 4 ↗
2026-04-15ANDREW CALLOS, EVP, Chief Commercial Officer$5,284,048
79,639 shplan 2025-09-05144 ↗
Form 4, 2026-04-15: sold 7,449 at $66.02 Form 4 ↗
2026-04-07FADY MALIK, EVP Research & Development$1,428,680
22,000 shplan 2025-12-23144 ↗
Form 4, 2026-04-08: sold 4,500 at $65.11 Form 4 ↗
2026-04-01ROBERT BLUM, President & CEO$2,965,950
45,000 shplan 2025-12-24144 ↗
Form 4, 2026-04-01: sold 7,500 at $66.63 Form 4 ↗
2026-03-31ANDREW CALLOS, EVP, Chief Commercial Officer$229,148
3,639 shplan 2025-09-05144 ↗
Form 4, 2026-03-31: sold 3,639 at $65.00 Form 4 ↗
2026-03-18ANDREW CALLOS, EVP, Chief Commercial Officer$119,911
1,930 shplan 2025-09-05144 ↗
Form 4, 2026-03-18: sold 1,930 at $62.07 Form 4 ↗
2026-03-16ANDREW CALLOS, EVP, Chief Commercial Officer$102,643
1,709 shplan 2025-09-05144 ↗
Form 4, 2026-03-16: sold 1,709 at $61.03 Form 4 ↗
2026-03-02B LYNNE PARSHALL, Director$622,200
10,000 shplan 2025-08-20144 ↗
Form 4, 2026-03-02: sold 5,000 at $61.21 Form 4 ↗
2026-01-02ANDREW CALLOS, EVP, Chief Commercial Officer$3,785,078
59,570 shplan 2025-09-05144 ↗
Form 4, 2026-01-02: sold 1,798 at $62.62 Form 4 ↗
2025-12-29ANDREW CALLOS, EVP, Chief Commercial Officer$114,166
1,809 shplan 2025-09-05144 ↗
Form 4, 2025-12-30: sold 1,809 at $62.44 Form 4 ↗
2025-12-22WENDELL WIERENGA, Director$1,254,400
20,000 shplan 2025-05-14144 ↗
Form 4, 2025-12-23: sold 20,000 at $66.14 Form 4 ↗
2025-12-05ANDREW CALLOS, EVP, Chief Commercial Officer$3,561,753
53,528 shplan 2025-09-05144 ↗
Form 4, 2025-12-05: sold 52,486 at $65.95 Form 4 ↗
2025-12-02JOHN T HENDERSON, Director$577,938
8,750 shplan 2025-09-02144 ↗
Form 4, 2025-12-02: sold 8,750 at $63.90 Form 4 ↗
2025-12-01EDWARD KAYE, Director$1,912,000
28,064 shplan 2025-03-06144 ↗
Form 4, 2025-12-02: sold 28,064 at $66.72 Form 4 ↗
2025-11-19B LYNNE PARSHALL, Director$330,800
5,000 shplan 2025-08-20144 ↗
Form 4, 2025-11-19: sold 5,000 at $64.73 Form 4 ↗
2025-11-11EDWARD KAYE, Director$321,885
5,175 shplan 2025-03-06144 ↗
Form 4, 2025-11-12: sold 5,175 at $65.08 Form 4 ↗
2025-10-27WENDELL WIERENGA, Director$253,006
4,375 shplan 2025-05-14144 ↗
Form 4, 2025-10-27: sold 4,375 at $58.68 Form 4 ↗
2025-10-21FADY MALIK, EVP Research & Development$652,850
11,000 shplan 2024-09-16144 ↗
Form 4, 2025-10-21: sold 2,105 at $58.22 Form 4 ↗